ACE Inhibitor and ARB utilization and expenditures in the Medicaid fee-for-service program from 1991 to 2008.

scientific article published in November 2010

ACE Inhibitor and ARB utilization and expenditures in the Medicaid fee-for-service program from 1991 to 2008. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.18553/JMCP.2010.16.9.671
P698PubMed publication ID21067253

P50authorPatricia R WigleQ79396881
P2093author name stringChristina M L Kelton
Jeff J Guo
Boyang Bian
P433issue9
P304page(s)671-679
P577publication date2010-11-01
P1433published inJournal of Managed Care PharmacyQ15757065
P1476titleACE Inhibitor and ARB utilization and expenditures in the Medicaid fee-for-service program from 1991 to 2008
P478volume16

Reverse relations

cites work (P2860)
Q98569237Adverse pregnancy outcomes associated with first-trimester exposure to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers: A systematic review and meta-analysis
Q89957914Angiotensin Receptor Blockers and the Risk of Cancer: Insights from Clinical Trials and Recent Drug Recalls
Q50237679Angiotensin-converting enzyme inhibitors reduce mortality compared to angiotensin receptor blockers: Systematic review and meta-analysis
Q34084060Antihypertensive medication classes used among medicare beneficiaries initiating treatment in 2007-2010.
Q36244740CAC score as a possible criterion for administration of angiotensin converting enzyme inhibitors and/or angiotensin receptor blockers: the MultiEthnic Study of Atherosclerosis
Q44890659Dynamic view on affordability of fixed-dose combination antihypertensive drug therapy
Q38621600Influencers of generic drug utilization: A systematic review
Q35137560New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition
Q35137270New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases.
Q87653504Patterns of antihypertensive medication use in kidney transplant recipients
Q90143446Trends in Antihypertensive Medication Monotherapy and Combination Use Among US Adults, National Health and Nutrition Examination Survey 2005-2016
Q93342807Trends in Utilization, Spending, and Prices of Smoking-Cessation Medications in Medicaid Programs: 25 Years Empirical Data Analysis, 1991-2015
Q47117956Utilization, Spending, and Price Trends for Quinolones in the US Medicaid Programs: 25 Years’ Experience 1991–2015.
Q43716093Utilization, spending, and price trends for benzodiazepines in the US Medicaid program: 1991-2009.

Search more.